Edward Carr
CHIEF ACCOUNTING OFFICER · 3 filings · Latest: Sep 17, 2026
Dianthus Therapeutics, Inc. /DE/
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
DNTH | Edward Carr | CHIEF ACCOUNTING OFFICER | Sep 17, 2026 | Sale | $101.38 | 20,000 | $2.0M | 0 | |
DNTH | Edward Carr | CHIEF ACCOUNTING OFFICER | Sep 17, 2026 | Option Exercise | $17.88 | 20,000 | $357.6K | 20,000 | |
DNTH | EDWARD CARR | — | Sep 17, 2026 | Proposed Sale | $102.49 | 20,000 | $2.0M | — | |
DNTH | Edward Carr | CHIEF ACCOUNTING OFFICER | Mar 12, 2026 | Sale | $81.49 | 43,682 | $3.6M | 0 | |
DNTH | Edward Carr | CHIEF ACCOUNTING OFFICER | Mar 12, 2026 | Option Exercise | $20.45 | 43,682 | $893.3K | 43,682 | |
DNTH | EDWARD CARR | — | Mar 12, 2026 | Proposed Sale | $85.84 | 43,682 | $3.7M | — |